Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
American Heart Journal
|
February 27, 1999
Predictability of response rates, efficacy, risks, and intolerance with sotalol when used for sustained ventricular arrhythmias
J A Reiffel
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 22, 2002
Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias
J A Reiffel
The American Journal of Cardiology
|
May 24, 2000
Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice
J A Reiffel
Current Opinion in Cardiology
|
February 10, 2000
Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues
J A Reiffel
Progress in Clinical and Biological Research
|
January 1, 1988
Clinical electrophysiology of the sinus node in man
J A Reiffel
Current Opinion in Cardiology
|
December 22, 2000
Issues in the use of generic antiarrhythmic drugs
J A Reiffel
American Heart Journal
|
April 1, 1992
Improved rate control in atrial fibrillation
J A Reiffel
Cardiology Clinics
|
August 1, 1986
Electrophysiologic evaluation of sinus node function
J A Reiffel
Journal of Cardiovascular Pharmacology and Therapeutics
|
January 11, 2001
The actions of ibutilide and class Ic drugs on the slow sodium channel: new insights regarding individual pharmacologic effects elucidated through combination therapies
J A Reiffel, M Blitzer
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1995
How do physicians determine when to perform an "on-drug" electrophysiology study for efficacy determination in patients with sustained ventricular tachyarrhythmias: a previously unaddressed variable that may affect efficacy rates
J A Reiffel, J Banker
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
American Heart Journal
|
February 27, 1999
Predictability of response rates, efficacy, risks, and intolerance with sotalol when used for sustained ventricular arrhythmias
J A Reiffel
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 22, 2002
Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias
J A Reiffel
The American Journal of Cardiology
|
May 24, 2000
Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice
J A Reiffel
Current Opinion in Cardiology
|
February 10, 2000
Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues
J A Reiffel
Progress in Clinical and Biological Research
|
January 1, 1988
Clinical electrophysiology of the sinus node in man
J A Reiffel
Current Opinion in Cardiology
|
December 22, 2000
Issues in the use of generic antiarrhythmic drugs
J A Reiffel
American Heart Journal
|
April 1, 1992
Improved rate control in atrial fibrillation
J A Reiffel
Cardiology Clinics
|
August 1, 1986
Electrophysiologic evaluation of sinus node function
J A Reiffel
Journal of Cardiovascular Pharmacology and Therapeutics
|
January 11, 2001
The actions of ibutilide and class Ic drugs on the slow sodium channel: new insights regarding individual pharmacologic effects elucidated through combination therapies
J A Reiffel, M Blitzer
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1995
How do physicians determine when to perform an "on-drug" electrophysiology study for efficacy determination in patients with sustained ventricular tachyarrhythmias: a previously unaddressed variable that may affect efficacy rates
J A Reiffel, J Banker
Page
of 9